Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect
Aspirin+and+vascular | PPT
Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com
Cardiovascular Disease Guidelines | Aspirin Foundation
Antiplatelet Medications - Summary Table Aspirin ... | GrepMed
Aspirin in primary prevention needs individual judgements | Nature Reviews Cardiology
P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials
Aspirin for Primary Prevention: Mind the Gap Segment | Core IM Podcast
A Critical Appraisal of Aspirin in Secondary Prevention | Circulation
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events
Secondary Prevention of Cardiovascular Disease CVD in Women
Arguments for and against aspirin use in secondary prevention of CHD... | Download Table
Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings | Irish Journal of Medical Science (1971 -)
Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012) - ScienceDirect
US Guidelines for Aspirin | The International Aspirin Foundation
Aspirin Use Discourged / 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology
Do I Need to Take a Daily Aspirin for Heart Prevention: Joel Kahn, MD: Integrative Cardiologist
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology
Guidelines on the use of Aspirin for Prevention of ASCVD - HealthDirect
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet
Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates
Aspirin in the Modern Era of Cardiovascular Disease Prevention - Methodist DeBakey Cardiovascular J
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect
Aspirin underused in secondary CVD prevention, especially in lower-income countries
Aspirin for Primary Prevention of Cardiovascular Events | Journal of the American College of Cardiology
Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
